Last reviewed · How we verify
Diagnostic Efficacy of Molecular Diagnostic Method for AMR in ABOiKT
The purpose of this study is to determine whether the peripheral blood marker-based molecular diagnostic method developed in the previous study can differentiate and predict accommodation and antibody-mediated rejection (AMR) in ABO blood type incompatible kidney transplant (ABOiKT) patients who are prospectively recruited.
Details
| Lead sponsor | Seoul National University Hospital |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 30 |
| Start date | Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Dec 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- ABO Blood Type Incompatible Kidney Transplantation
- Antibody-mediated Rejection
Interventions
- 5-gene classification model
Countries
South Korea